Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Envafolimab Combined With Endostatin in Recurrent or Metastatic MSS-type Colorectal Cancer

ABSTRACT: The objective is to investigate the efficacy and safety of envafolimab combined with recombinant human endostatin (endostatin) in the treatment of MSS-type colorectal cancer patients with recurrence or metastasis after failure of second-line standard therapy.

DISEASE(S): Colorectal Neoplasms

PROVIDER: 2749194 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

ACCESS DATA

Json Xml

Similar Datasets

Transcription profiling of human dermal endothelial cells treated with 200ng/ml human recombinant endostatin for 6h

Project description:Cells were treated with 200ng/ml human recombinant endostatin (Pichia Pastoris) for 6h at 37C with 5 % CO2 and 95 % humidity.

2007-04-25 | E-RZPD-20 | biostudies-arrayexpress

Transcription profiling of human dermal enothelial cells treated with 200ng/ml human recombinant endostatin (Pichia Pastoris)

Project description:Cells were treated with 200ng/ml human recombinant endostatin (Pichia Pastoris) for 6h at 37°C with 5 % CO2 and 95 % humidity.

2013-01-30 | E-RZPD-10 | biostudies-arrayexpress

Recombinant Human Endostatin in Combination With mFOLFOX6 in Patients With Metastatic Colorectal Cancer

Project description:To investigate safety and tolerance of dose-escalation of infusional recombinant human endostatin in combination with mFOLFOX6 as initial therapy for patients with metastatic colorectal cancer.

| 2103392 | ecrin-mdr-crc

Citrobacter freundii strain:MSS-CF17

Project description:Citrobacter freundii strain:MSS-CF17 Genome sequencing and assembly

| PRJNA950610 | ENA

Expression profiles of a panel of MSS and MSI colon cancer cell lines

Project description:Expression profiling was used to identify genes differentially expressed in MSS (microsatellite stable) and MSI (microsatellite unstable) colon cancer cell lines. Data submitted in support of manuscript entitled Villin expression is frequently lost in poorly differentiated colon cancer, Diego Arango, Sheren Al-Obaidi, David S. Williams, Jose Dopeso, Rocco Mazzolini, Georgia Corner, Do-Sun Byun, Carmel Murone, Lars Tögel, Nikolajs Zeps, Lauri A. Aaltonen, Barry Iacopetta and John M. Mariadason, American Journal of Pathology, 2012. 5 microsatellite stable (MSS) and 5 microsatellite unstable (MSI) colon cancer cell lines profiled. Each cell line grown and arrayed in duplicate, and the duplicates averaged for each cell line before calculating means for MSS and MSI lines.

2012-02-07 | E-GEOD-35566 | biostudies-arrayexpress

Cetuximab and Envafolimab Plus mFOLFOXIRI as First-line Treatment for RAS/BRAF Wild-type, MSS, Unresectable Left-side Metastatic Colorectal Cancer

Project description:The primary aim of phase II CEIL study is to evaluate the efficacy of cetuximab and envafolimab plus mFOLFOXIRI versus cetuximab plus mFOLFOX6/FOLFIRI as first line treatment of patients with initially unresectable and previously untreated RAS/BRAF wild-type, MSS, left-side metastatic colorectal cancer(mCRC), in terms of Progression-free Survival.

| 70494 | ecrin-mdr-crc

Recombinant Human Endostatin in Combination With XELOX Therapy in Patient With Advanced Colorectal Cancer.

Project description:To study safety and efficacy of intravenous pump of recombinant human endostatin combined with XELOX-treated and also investigate the potential value of CECs level for the prediction of PD and outcomes in patients with advanced colorectal cancer.

| 2276938 | ecrin-mdr-crc

Expression data for 52 microsatellite stable (MSS) primary tumors from patients with proximal colon cancer.

Project description:Samples were taken from surgically resected tumor specimens from patients with proximal colon cancer. The expression profiles were determined using the Affymetrix GeneChip Human Exon 1.0 ST Array version 2. APC gene mutation status was determined using Sanger sequencing. A classifier for APC mutation status was trained using these expression data. 52 microsatellite stable (MSS) proximal colon cancers samples were analyzed. 17 samples were APC wild-type and 35 had APC protein-truncating mutations.

2016-03-02 | E-GEOD-63624 | biostudies-arrayexpress

Expression profiles of a panel of MSS and MSI colon cancer cell lines

2012-02-07 | GSE35566 | GEO

Dysfunctional tumor-infiltrating Vδ1+ T lymphocytes in MSS colorectal cancer

Project description:Dysfunctional tumor-infiltrating Vδ1+ T lymphocytes in MSS colorectal cancer

| PRJNA990732 | ENA